Send me a link:

*Text messaging rates may apply.

 Dow Down 1.88% Nasdaq Down 2.09%

Stemline Therapeutics, Inc. (STML)

-NasdaqCM
12.81 0.87(6.36%) Jul 31, 3:59PM EDT
Prev Close:13.68
Open:13.46
Bid:10.01 x 400
Ask:19.47 x 500
1y Target Est:56.00
Beta:-4.709
Earnings Date:Aug 11 - Aug 15 (Est.)
Day's Range:12.58 - 13.50
52wk Range:10.68 - 47.25
Volume:102,918
Avg Vol (3m):133,156
Market Cap:165.22M
P/E (ttm):N/A
EPS (ttm):-2.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for STML

Comparison

Symbol% ChgMkt Cap
STMLDown 6.36%165.22M
OMED638.39M
VSTM190.91M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,242.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.81
Quarterly EPS Est (Jun-14) :-0.69
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback